Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

Yuning Liao(Guangzhou Medical University Cancer Hospital), Hongbiao Huang(Guangzhou Medical University Cancer Hospital)
Journal of Experimental & Clinical Cancer Research
April 11, 2019
Cited by 101


Related Papers